• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

胃抑制多肽(GIP)受体激动作用通过不同的神经回路抑制炎症诱导的厌恶和食物摄入。

GIP receptor agonism suppresses inflammation-induced aversion and food intake via distinct circuits.

作者信息

Province Haley S, Hayes Nikolas W, Leong Nathan A, Lorch Carolyn M, Pekerman Alexandra, Xia Jessica L, Beutler Lisa R

机构信息

Department of Medicine, Division of Endocrinology, Metabolism and Molecular Medicine, Northwestern University, Chicago, IL 60611, USA.

Northwestern Interdepartmental Neuroscience Graduate Program, Northwestern University, Chicago, IL 60611, USA.

出版信息

bioRxiv. 2025 Aug 15:2025.08.12.669936. doi: 10.1101/2025.08.12.669936.

DOI:10.1101/2025.08.12.669936
PMID:40832329
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12363899/
Abstract

Glucose-dependent insulinotropic polypeptide (GIP) is a gut-derived incretin hormone, and pharmacologic modulation of central GIP receptors (GIPR) improves energy homeostasis. Recent reports have demonstrated that GIPR agonism is also anti-aversive. However, the mechanisms by which GIPR signaling impact food intake and aversion are incompletely understood. Here, we show that GIPR agonism abrogates the aversive and enhances the anorexigenic effects of the pro-inflammatory cytokine interleukin-1β (IL-1β). Aversion-encoding parabrachial calcitonin-gene related peptide (CGRP) neurons were required for IL-1β-induced conditioned taste avoidance (CTA) but not anorexia. Moreover, systemic IL-1β increased CGRP neural activity, and this was significantly attenuated by co-administration of a GIPR agonist. By contrast, GIPR in the dorsal vagal complex were required for the acute anorectic effect of GIPR agonism but not its anti-aversive effect. Taken together, our data suggest that GIPR agonism reduces food intake and prevents aversion via distinct circuits, and that GIPR agonism may represent an effective approach to alleviate inflammation-induced aversion.

摘要

葡萄糖依赖性促胰岛素多肽(GIP)是一种源自肠道的肠促胰岛素激素,对中枢GIP受体(GIPR)进行药理学调节可改善能量平衡。最近的报告表明,GIPR激动作用也具有抗厌恶作用。然而,GIPR信号传导影响食物摄入和厌恶的机制尚未完全明确。在此,我们表明GIPR激动作用可消除促炎细胞因子白细胞介素-1β(IL-1β)的厌恶作用,并增强其厌食作用。编码厌恶的臂旁降钙素基因相关肽(CGRP)神经元是IL-1β诱导的条件性味觉回避(CTA)所必需的,但不是厌食所必需的。此外,全身性IL-1β增加了CGRP神经活动,而GIPR激动剂的共同给药可显著减弱这种活动。相比之下,迷走神经背侧复合体中的GIPR是GIPR激动作用的急性厌食作用所必需的,但不是其抗厌恶作用所必需的。综上所述,我们的数据表明,GIPR激动作用通过不同的神经回路减少食物摄入并防止厌恶,并且GIPR激动作用可能是减轻炎症诱导的厌恶的有效方法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e0ba/12363899/49512656e9f6/nihpp-2025.08.12.669936v1-f0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e0ba/12363899/f972924d2a7a/nihpp-2025.08.12.669936v1-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e0ba/12363899/73351cf2cc10/nihpp-2025.08.12.669936v1-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e0ba/12363899/6dcc0456081d/nihpp-2025.08.12.669936v1-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e0ba/12363899/c1f22258690d/nihpp-2025.08.12.669936v1-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e0ba/12363899/49512656e9f6/nihpp-2025.08.12.669936v1-f0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e0ba/12363899/f972924d2a7a/nihpp-2025.08.12.669936v1-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e0ba/12363899/73351cf2cc10/nihpp-2025.08.12.669936v1-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e0ba/12363899/6dcc0456081d/nihpp-2025.08.12.669936v1-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e0ba/12363899/c1f22258690d/nihpp-2025.08.12.669936v1-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e0ba/12363899/49512656e9f6/nihpp-2025.08.12.669936v1-f0005.jpg

相似文献

1
GIP receptor agonism suppresses inflammation-induced aversion and food intake via distinct circuits.胃抑制多肽(GIP)受体激动作用通过不同的神经回路抑制炎症诱导的厌恶和食物摄入。
bioRxiv. 2025 Aug 15:2025.08.12.669936. doi: 10.1101/2025.08.12.669936.
2
Selective release of gastrointestinal hormones induced by an orally active GPR39 agonist.口服活性 GPR39 激动剂诱导的胃肠激素的选择性释放。
Mol Metab. 2021 Jul;49:101207. doi: 10.1016/j.molmet.2021.101207. Epub 2021 Mar 9.
3
GIPR agonism and antagonism decrease body weight and food intake via different mechanisms in male mice.在雄性小鼠中,胃抑制多肽受体(GIPR)激动和拮抗通过不同机制降低体重和食物摄入量。
Nat Metab. 2025 Apr 29. doi: 10.1038/s42255-025-01294-x.
4
Metformin Boosts Intestinal Lipid Sensing via GIP to Suppress Feeding.二甲双胍通过胃抑肽增强肠道脂质感知以抑制进食。
Diabetes. 2025 Jul 22. doi: 10.2337/db25-0100.
5
Glucose-Dependent Insulinotropic Polypeptide Is Involved in Postprandial Regulation of Splanchnic Blood Supply.葡萄糖依赖性促胰岛素多肽参与餐后内脏血液供应的调节。
Diabetes. 2025 Aug 1;74(8):1355-1366. doi: 10.2337/db25-0149.
6
A Contemporary Rationale for Agonism of the GIP Receptor in the Treatment of Obesity.GIP受体激动剂治疗肥胖症的当代理论依据
Diabetes. 2025 Aug 1;74(8):1326-1333. doi: 10.2337/dbi24-0026.
7
The incretin co-agonist tirzepatide requires GIPR for hormone secretion from human islets.肠促胰岛素共激动剂替西帕肽需要 GIPR 才能从人胰岛中分泌激素。
Nat Metab. 2023 Jun;5(6):945-954. doi: 10.1038/s42255-023-00811-0. Epub 2023 Jun 5.
8
Glucose-dependent insulinotropic polypeptide receptor signaling in oligodendrocytes increases the weight-loss action of GLP-1R agonism.少突胶质细胞中葡萄糖依赖性促胰岛素多肽受体信号传导增强了胰高血糖素样肽-1受体激动剂的减肥作用。
Cell Metab. 2025 Sep 2;37(9):1820-1834.e5. doi: 10.1016/j.cmet.2025.07.009. Epub 2025 Aug 13.
9
Incretin receptor agonism rapidly inhibits AgRP neurons to suppress food intake in mice.肠促胰岛素受体激动可迅速抑制小鼠的AgRP神经元,从而抑制食物摄入。
J Clin Invest. 2025 Aug 26. doi: 10.1172/JCI186652.
10
Prescription of Controlled Substances: Benefits and Risks管制药品的处方:益处与风险

本文引用的文献

1
GIPR agonism and antagonism decrease body weight and food intake via different mechanisms in male mice.在雄性小鼠中,胃抑制多肽受体(GIPR)激动和拮抗通过不同机制降低体重和食物摄入量。
Nat Metab. 2025 Apr 29. doi: 10.1038/s42255-025-01294-x.
2
A neural mechanism for learning from delayed postingestive feedback.一种从延迟的摄食后反馈中学习的神经机制。
Nature. 2025 Apr 2. doi: 10.1038/s41586-025-08828-z.
3
Specific loss of GIPR signaling in GABAergic neurons enhances GLP-1R agonist-induced body weight loss.γ-氨基丁酸能神经元中胃抑制多肽受体(GIPR)信号的特异性缺失增强了胰高血糖素样肽-1受体(GLP-1R)激动剂诱导的体重减轻。
Mol Metab. 2025 May;95:102074. doi: 10.1016/j.molmet.2024.102074. Epub 2024 Nov 26.
4
A long-acting glucose-dependent insulinotropic polypeptide receptor agonist improves the gastrointestinal tolerability of glucagon-like peptide-1 receptor agonist therapy.一种长效葡萄糖依赖性促胰岛素多肽受体激动剂可改善胰高血糖素样肽-1受体激动剂疗法的胃肠道耐受性。
Diabetes Obes Metab. 2024 Nov;26(11):5474-5478. doi: 10.1111/dom.15875. Epub 2024 Aug 27.
5
Dissociable hindbrain GLP1R circuits for satiety and aversion.饱腹感和厌恶感的可分离后脑 GLP1R 回路。
Nature. 2024 Aug;632(8025):585-593. doi: 10.1038/s41586-024-07685-6. Epub 2024 Jul 10.
6
A body-brain circuit that regulates body inflammatory responses.调控身体炎症反应的体脑回路。
Nature. 2024 Jun;630(8017):695-703. doi: 10.1038/s41586-024-07469-y. Epub 2024 May 1.
7
The antiemetic actions of GIP receptor agonism.GIP 受体激动剂的止吐作用。
Am J Physiol Endocrinol Metab. 2024 Apr 1;326(4):E528-E536. doi: 10.1152/ajpendo.00330.2023. Epub 2024 Mar 13.
8
A GIPR antagonist conjugated to GLP-1 analogues promotes weight loss with improved metabolic parameters in preclinical and phase 1 settings.一种与 GLP-1 类似物偶联的 GIPR 拮抗剂在临床前和 1 期研究中可促进体重减轻,并改善代谢参数。
Nat Metab. 2024 Feb;6(2):290-303. doi: 10.1038/s42255-023-00966-w. Epub 2024 Feb 5.
9
Sucrose overconsumption impairs AgRP neuron dynamics and promotes palatable food intake.蔗糖过度摄入会损害 AgRP 神经元的活动,并促进美味食物的摄入。
Cell Rep. 2024 Feb 27;43(2):113675. doi: 10.1016/j.celrep.2024.113675. Epub 2024 Jan 14.
10
Glucose-dependent insulinotropic polypeptide regulates body weight and food intake via GABAergic neurons in mice.葡萄糖依赖性胰岛素多肽通过小鼠中的 GABA 能神经元调节体重和食物摄入。
Nat Metab. 2023 Dec;5(12):2075-2085. doi: 10.1038/s42255-023-00931-7. Epub 2023 Nov 9.